Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2023 Filed Mar 2, 2023 14:37 UTC |
JONES DAVID A JR/KYDirector
|
GiftHumana Common | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005464 · form4.xml · nonDerivative · entry 3 JONES DAVID A JR/KY · CIK 0001025393 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 32,440 F6 · shares: Shares disposed of represent a gift/charitable donation, effective February 28, 2023, in which no value was received in return. F4 · ownership.nature: Shares held by a revocable trust account (Dec 2009), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 19:19 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
SaleHumana Common | 17,575 | $505.85 | $8,890,232.91 |
DisclosureSEC source: 0001062993-23-005077 · form4.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,040 F11 · price: Price reported is weighted average sales price. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 19:02 UTC |
Ventura Joseph CChief Legal Officer
|
GiftHumana Common | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005075 · form4.xml · nonDerivative · entry 4 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,187 F13 · shares: Disposition reported represents gift/charitable donation, effective February 27, 2023, in which no value was received in return. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 19:02 UTC |
Ventura Joseph CChief Legal Officer
|
SaleHumana Common | 2,048 | $507.97 | $1,040,328.29 |
DisclosureSEC source: 0001062993-23-005075 · form4.xml · nonDerivative · entry 3 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,256 F12 · price: Price reported is weighted average sales price. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 18:51 UTC |
Huval Timothy S.Chief Administrative Officer
|
SaleHumana Common | 2,628 | $510.30 | $1,341,079.70 |
DisclosureSEC source: 0001062993-23-005073 · form4.xml · nonDerivative · entry 3 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,968 F12 · price: Price reported is weighted average sales price. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 19:19 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 6,859 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005077 · form4.xml · derivative · entry 10 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,859 Underlying: Humana Common · 6,859 shares Expires not disclosed F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 19:19 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
GrantOptions · Derivative | 26,484 | $0.00 Strike: $510.24 | $0.00 |
DisclosureSEC source: 0001062993-23-005077 · form4.xml · derivative · entry 7 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,484 Underlying: Humana Common · 26,484 shares Expires 2030-02-24 F4 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. F4 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 19:19 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Tax withholdingHumana Common | 10,919 | $510.24 | $5,571,337.86 |
DisclosureSEC source: 0001062993-23-005077 · form4.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,615 F10 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/24/23. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 19:19 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Exercise / conversionHumana Common | 28,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005077 · form4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · shares: Performance Stock Units vested on 2/24/23, not required to be reported until vest. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 19:02 UTC |
Ventura Joseph CChief Legal Officer
|
GrantRestricted Stock Units · Derivative | 1,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005075 · form4.xml · derivative · entry 12 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078 Underlying: Humana Common · 1,078 shares Expires not disclosed F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 19:02 UTC |
Ventura Joseph CChief Legal Officer
|
GrantOptions · Derivative | 4,162 | $0.00 Strike: $510.24 | $0.00 |
DisclosureSEC source: 0001062993-23-005075 · form4.xml · derivative · entry 9 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,162 Underlying: Humana Common · 4,162 shares Expires 2030-02-24 F5 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. F5 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 19:02 UTC |
Ventura Joseph CChief Legal Officer
|
Tax withholdingHumana Common | 1,245 | $510.24 | $635,251.91 |
DisclosureSEC source: 0001062993-23-005075 · form4.xml · nonDerivative · entry 2 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,304 F11 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/24/23. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 19:02 UTC |
Ventura Joseph CChief Legal Officer
|
Exercise / conversionHumana Common | 3,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005075 · form4.xml · nonDerivative · entry 1 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · shares: Performance Stock Units vested on 2/24/23, not required to be reported until vest. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 18:51 UTC |
Huval Timothy S.Chief Administrative Officer
|
GrantRestricted Stock Units · Derivative | 1,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005073 · form4.xml · derivative · entry 11 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,029 Underlying: Humana Common · 1,029 shares Expires not disclosed F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 18:51 UTC |
Huval Timothy S.Chief Administrative Officer
|
GrantOptions · Derivative | 3,973 | $0.00 Strike: $510.24 | $0.00 |
DisclosureSEC source: 0001062993-23-005073 · form4.xml · derivative · entry 8 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,973 Underlying: Humana Common · 3,973 shares Expires 2030-02-24 F5 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2023, vesting in three annual increments from 2/21/24 to 2/21/26. F5 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2023, vesting in three annual increments from 2/21/24 to 2/21/26. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 18:51 UTC |
Huval Timothy S.Chief Administrative Officer
|
Tax withholdingHumana Common | 1,678 | $510.24 | $856,186.92 |
DisclosureSEC source: 0001062993-23-005073 · form4.xml · nonDerivative · entry 2 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,596 F11 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/24/23. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 18:51 UTC |
Huval Timothy S.Chief Administrative Officer
|
Exercise / conversionHumana Common | 4,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005073 · form4.xml · nonDerivative · entry 1 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · shares: Performance Stock Units vested on 2/24/23, not required to be reported until vest. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 17:39 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
GrantRestricted Stock Units · Derivative | 931 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005071 · form4.xml · derivative · entry 11 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 931 Underlying: Humana Common · 931 shares Expires not disclosed F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F10 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F10 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 17:39 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
GrantOptions · Derivative | 3,594 | $0.00 Strike: $510.24 | $0.00 |
DisclosureSEC source: 0001062993-23-005071 · form4.xml · derivative · entry 8 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,594 Underlying: Humana Common · 3,594 shares Expires 2030-02-24 F6 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. F6 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 17:39 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
Tax withholdingHumana Common | 1,427 | $510.24 | $728,116.05 |
DisclosureSEC source: 0001062993-23-005071 · form4.xml · nonDerivative · entry 2 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,316 F12 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/24/23. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 17:39 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
Exercise / conversionHumana Common | 3,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005071 · form4.xml · nonDerivative · entry 1 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · shares: Performance Stock Units vested on 2/24/23, not required to be reported until vest. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 17:38 UTC |
Renaudin George IIPresident, Medicare & Medicaid
|
GrantRestricted Stock Units · Derivative | 1,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005069 · form4.xml · derivative · entry 9 Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078 Underlying: Humana Common · 1,078 shares Expires not disclosed F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 17:38 UTC |
Renaudin George IIPresident, Medicare & Medicaid
|
GrantOptions · Derivative | 4,162 | $0.00 Strike: $510.24 | $0.00 |
DisclosureSEC source: 0001062993-23-005069 · form4.xml · derivative · entry 4 Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,162 Underlying: Humana Common · 4,162 shares Expires 2030-02-24 F2 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. F2 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 17:38 UTC |
Renaudin George IIPresident, Medicare & Medicaid
|
Tax withholdingHumana Common | 347 | $510.24 | $177,054.15 |
DisclosureSEC source: 0001062993-23-005069 · form4.xml · nonDerivative · entry 2 Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,046 F11 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/24/23. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 17:38 UTC |
Renaudin George IIPresident, Medicare & Medicaid
|
Exercise / conversionHumana Common | 1,393 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005069 · form4.xml · nonDerivative · entry 1 Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,393 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · shares: Performance Stock Units vested on 2/24/23, not required to be reported until vest. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 17:34 UTC |
Schick Susan D.Seg Pres. Grp. & Military Bus.
|
Tax withholdingHumana Common | 399 | $510.24 | $203,586.76 |
DisclosureSEC source: 0001062993-23-005067 · form4.xml · nonDerivative · entry 2 Schick Susan D. · CIK 0001881150 · Seg Pres. Grp. & Military Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,687 F8 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/24/23. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 17:34 UTC |
Schick Susan D.Seg Pres. Grp. & Military Bus.
|
Exercise / conversionHumana Common | 1,267 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005067 · form4.xml · nonDerivative · entry 1 Schick Susan D. · CIK 0001881150 · Seg Pres. Grp. & Military Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · shares: Performance Stock Units vested on 2/24/23, not required to be reported until vest. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:49 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
GrantRestricted Stock Units · Derivative | 958 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005050 · form4.xml · derivative · entry 12 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 958 Underlying: Humana Common · 958 shares Expires not disclosed F8 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F11 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F11 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:49 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
GrantOptions · Derivative | 3,698 | $0.00 Strike: $510.24 | $0.00 |
DisclosureSEC source: 0001062993-23-005050 · form4.xml · derivative · entry 9 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,698 Underlying: Humana Common · 3,698 shares Expires 2030-02-24 F7 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. F8 · derivative.exercise_date: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:49 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Tax withholdingHumana Common | 1,802 | $510.24 | $919,456.99 |
DisclosureSEC source: 0001062993-23-005050 · form4.xml · nonDerivative · entry 2 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,027 F14 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/24/23. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:49 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Exercise / conversionHumana Common | 4,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005050 · form4.xml · nonDerivative · entry 1 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · shares: Performance Stock Units vested on 2/24/23, not required to be reported until vest. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:27 UTC |
Agwunobi, M.D. Andrew C.Seg. President, Home Solutions
|
GrantRestricted Stock Units · Derivative | 735 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005046 · form4.xml · derivative · entry 5 Agwunobi, M.D. Andrew C. · CIK 0001365029 · Seg. President, Home Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 735 Underlying: Humana Common · 735 shares Expires not disclosed F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:27 UTC |
Agwunobi, M.D. Andrew C.Seg. President, Home Solutions
|
GrantOptions · Derivative | 2,838 | $0.00 Strike: $510.24 | $0.00 |
DisclosureSEC source: 0001062993-23-005046 · form4.xml · derivative · entry 3 Agwunobi, M.D. Andrew C. · CIK 0001365029 · Seg. President, Home Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,838 Underlying: Humana Common · 2,838 shares Expires 2030-02-24 F2 · security: Right to buy pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. F2 · derivative.exercise_date: Right to buy pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:35 UTC |
Deshpande SamirChief Information Officer
|
GrantRestricted Stock Units · Derivative | 1,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005048 · form4.xml · derivative · entry 9 Deshpande Samir · CIK 0001712481 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004 Underlying: Humana Common · 1,004 shares Expires not disclosed F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:35 UTC |
Deshpande SamirChief Information Officer
|
GrantOptions · Derivative | 3,878 | $0.00 Strike: $510.24 | $0.00 |
DisclosureSEC source: 0001062993-23-005048 · form4.xml · derivative · entry 6 Deshpande Samir · CIK 0001712481 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,878 Underlying: Humana Common · 3,878 shares Expires 2030-02-24 F4 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. F4 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:35 UTC |
Deshpande SamirChief Information Officer
|
Tax withholdingHumana Common | 1,541 | $510.24 | $786,283.69 |
DisclosureSEC source: 0001062993-23-005048 · form4.xml · nonDerivative · entry 2 Deshpande Samir · CIK 0001712481 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,360 F10 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/24/23. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:35 UTC |
Deshpande SamirChief Information Officer
|
Exercise / conversionHumana Common | 4,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005048 · form4.xml · nonDerivative · entry 1 Deshpande Samir · CIK 0001712481 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · shares: Performance Stock Units vested on 2/24/23, not required to be reported until vest. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:18 UTC |
Felter John-Paul W.SVP, Chief Accting Off & Cont.
|
GrantRestricted Stock Units · Derivative | 343 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005040 · form4.xml · derivative · entry 3 Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343 Underlying: Humana Common · 343 shares Expires not disclosed F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_date: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F3 · derivative.expiration_date: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:15 UTC |
Diamond Susan MChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 1,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005038 · form4.xml · derivative · entry 12 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,764 Underlying: Humana Common · 1,764 shares Expires not disclosed F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F11 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F11 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:15 UTC |
Diamond Susan MChief Financial Officer
|
GrantOptions · Derivative | 6,810 | $0.00 Strike: $510.24 | $0.00 |
DisclosureSEC source: 0001062993-23-005038 · form4.xml · derivative · entry 8 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,810 Underlying: Humana Common · 6,810 shares Expires 2030-02-24 F6 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. F6 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:15 UTC |
Diamond Susan MChief Financial Officer
|
Tax withholdingHumana Common | 1,125 | $510.24 | $574,022.81 |
DisclosureSEC source: 0001062993-23-005038 · form4.xml · nonDerivative · entry 2 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,718 F14 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/24/23. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:15 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionHumana Common | 3,039 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005038 · form4.xml · nonDerivative · entry 1 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · shares: Performance Stock Units vested on 2/24/23, not required to be reported until vest. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 18:46 UTC |
Klevorn Marcy SDirector
|
GrantRestricted Stock Units · Derivative | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000149 · form4.xml · derivative · entry 4 Klevorn Marcy S · CIK 0001692367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380 Underlying: Humana Common · 380 shares Expires not disclosed F3 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 23:38 UTC |
Garratt John WDirector
|
GrantRestricted Stock Units · Derivative | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000414 · form4.xml · derivative · entry 2 Garratt John W · CIK 0001646121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380 Underlying: Humana Common · 380 shares Expires not disclosed F1 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2023. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2023. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2023. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2023. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 17:42 UTC |
Mesquita Jorge S.Director
|
GrantHumana Common | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000126 · form4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,603 F1 · balance_after: Includes 380 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting 12/31/23. F2 · balance_after: Due to scrivener's error, 375 shares purchased and reported on 3/8/21 were inadvertently not carried forward on previous Form 4. Shares reported reflect accurate holdings. F3 · ownership.nature: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003. Shares were incorrectly reported as Direct holdings on previous Form 4. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 23:39 UTC |
Bono Raquel C.Director
|
GrantRestricted Stock Units · Derivative | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000416 · form4.xml · derivative · entry 4 Bono Raquel C. · CIK 0001823759 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380 Underlying: Humana Common · 380 shares Expires not disclosed F3 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 23:37 UTC |
KATZ KARENDirector
|
GrantRestricted Stock Units · Derivative | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000412 · form4.xml · derivative · entry 5 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380 Underlying: Humana Common · 380 shares Expires not disclosed F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 22:46 UTC |
SMITH BRAD DDirector
|
GrantRestricted Stock Units · Derivative | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000398 · form4.xml · derivative · entry 3 SMITH BRAD D · CIK 0001284323 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380 Underlying: Humana Common · 380 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 20:44 UTC |
DAMELIO FRANK ADirector
|
GrantRestricted Stock Units · Derivative | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000199 · form4.xml · derivative · entry 6 DAMELIO FRANK A · CIK 0001194004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380 Underlying: Humana Common · 380 shares Expires not disclosed F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/23. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/23. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/23. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/23. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 20:32 UTC |
Feinberg David TDirector
|
GrantRestricted Stock Units · Derivative | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000191 · form4.xml · derivative · entry 3 Feinberg David T · CIK 0001486426 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380 Underlying: Humana Common · 380 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.